Privi Speciality Chemicals Ltd

AI

Privi Speciality Chemicals Ltd

₹ 3,275 0.10%
04 Nov - close price
About

Incorporated in 1985, Privi Speciality Chemicals Ltd (Formerly known as Privi Speciality Ltd.) is primarily engaged in the manufacturing, supply and exports of aroma and fragrance chemicals used in soaps, detergents, shampoos, and other fine fragrances. [1]

Key Points

Business Profile[1]
Privi Speciality Chemicals Limited, formerly Fairchem Speciality Limited, is India’s largest manufacturer and exporter of aroma chemicals, holding a >20% global market share in ten products. The company specializes in manufacturing, supplying, and exporting bulk aroma and fragrance chemicals.[2]

  • Market Cap ₹ 12,792 Cr.
  • Current Price ₹ 3,275
  • High / Low ₹ 3,785 / 2,569
  • Stock P/E 32.6
  • Book Value ₹ 410
  • Dividend Yield 0.31 %
  • ROCE 26.6 %
  • ROE 28.2 %
  • Face Value ₹ 10.0

Pros

  • Company has delivered good profit growth of 29.0% CAGR over last 5 years
  • Company's median sales growth is 16.2% of last 10 years

Cons

  • Stock is trading at 7.99 times its book value
  • Promoter holding has decreased over last 3 years: -13.4%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
430 401 476 441 518 498 581 566 656 573 660 601 723
344 308 382 347 407 387 454 430 472 417 478 455 527
Operating Profit 86 93 94 94 111 111 127 136 184 155 182 146 196
OPM % 20% 23% 20% 21% 21% 22% 22% 24% 28% 27% 28% 24% 27%
4 5 7 2 4 1 14 8 0 6 3 15 11
Interest 25 24 24 21 21 20 21 20 18 15 15 13 13
Depreciation 30 32 31 31 32 32 32 33 32 32 33 34 34
Profit before tax 36 43 46 43 63 60 88 92 134 115 138 113 160
Tax % 26% 26% 26% 26% 26% 26% 25% 25% 25% 25% 25% 25% 25%
27 32 34 32 47 44 66 69 100 86 103 84 119
EPS in Rs 6.81 8.17 8.78 8.24 11.92 11.35 16.91 17.57 25.66 21.92 26.27 21.55 30.51
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
151 152 185 236 250 1,295 1,255 1,391 1,578 1,712 2,038 2,456 2,556
126 128 162 202 213 1,080 1,048 1,195 1,394 1,383 1,590 1,795 1,877
Operating Profit 25 23 24 34 36 215 207 197 184 329 448 661 679
OPM % 17% 15% 13% 14% 15% 17% 16% 14% 12% 19% 22% 27% 27%
1 0 0 3 4 66 43 38 21 21 18 17 35
Interest 3 4 5 6 6 36 23 25 68 97 85 68 56
Depreciation 2 3 4 5 5 55 69 73 105 122 127 130 133
Profit before tax 21 17 15 26 29 189 158 137 31 132 254 479 525
Tax % 33% 36% 39% 25% 26% 24% 26% 26% 28% 26% 25% 25%
14 11 9 19 22 144 117 102 22 98 189 357 392
EPS in Rs 9.92 7.68 2.41 5.16 5.50 36.83 29.93 26.00 5.75 25.03 48.41 91.42 100.25
Dividend Payout % 25% 33% 42% 29% 45% 4% 7% 8% 0% 8% 10% 11%
Compounded Sales Growth
10 Years: 32%
5 Years: 14%
3 Years: 16%
TTM: 11%
Compounded Profit Growth
10 Years: 42%
5 Years: 29%
3 Years: 150%
TTM: 40%
Stock Price CAGR
10 Years: 23%
5 Years: 14%
3 Years: 37%
1 Year: 10%
Return on Equity
10 Years: 17%
5 Years: 16%
3 Years: 20%
Last Year: 28%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 14 14 38 38 39 39 39 39 39 39 39 39 39
Reserves 43 49 33 48 64 564 675 768 783 881 1,062 1,399 1,563
29 34 60 67 57 493 517 897 1,043 900 856 729 705
20 18 23 24 28 269 291 424 478 368 516 717 711
Total Liabilities 105 114 154 176 188 1,364 1,522 2,128 2,343 2,189 2,473 2,883 3,018
62 73 94 102 115 564 565 666 982 999 979 1,005 970
CWIP 8 5 3 3 1 30 174 370 93 27 70 234 362
Investments 0 0 0 0 0 43 43 51 51 62 62 112 117
36 36 57 72 72 727 740 1,042 1,217 1,101 1,363 1,532 1,569
Total Assets 105 114 154 176 188 1,364 1,522 2,128 2,343 2,189 2,473 2,883 3,018

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
32 16 4 15 34 216 152 15 55 362 304 559
-25 -13 -20 -13 -14 -174 -242 -324 -141 -118 -144 -354
-7 -3 17 -3 -21 29 19 324 70 -239 -135 -212
Net Cash Flow 0 -0 0 -0 0 72 -71 15 -16 6 25 -7
Free Cash Flow 7 3 4 15 17 46 -90 -301 -87 259 156 256
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 150% 81% 36% 61% 107% 131% 92% 24% 37% 118% 84% 102%

Ratios

Standalone / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 42 41 50 49 47 61 69 75 73 77 72 87
Inventory Days 50 49 69 71 76 145 158 254 293 229 246 222
Days Payable 28 10 18 17 22 74 91 140 117 108 138 167
Cash Conversion Cycle 65 80 101 103 101 132 136 189 249 198 180 142
Working Capital Days 18 6 3 9 8 32 63 18 15 41 37 57
ROCE % 29% 23% 17% 22% 23% 30% 14% 11% 6% 12% 18% 27%

Insights

In beta
Jul 2016 Jul 2017 Sep 2020 Jan 2022 Mar 2023 Jul 2024 May 2026
Sales Volume
MT

Log in to view insights

Please log in to see hidden values.

Login
Number of Countries Exported To
count
Number of Manufacturing Facilities
count
CST Processing Capacity
MTPA
Number of Products
count
Total Production Capacity
MTPA
R&D Team Strength
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
74.05% 74.05% 74.05% 74.05% 74.05% 74.05% 69.89% 69.89% 60.60% 60.60% 60.60% 60.60%
0.96% 0.62% 0.48% 0.43% 0.48% 0.40% 1.47% 1.33% 1.64% 1.37% 1.94% 2.78%
3.39% 3.37% 2.84% 2.49% 2.09% 1.95% 3.90% 4.55% 10.25% 10.67% 10.07% 8.96%
21.59% 21.95% 22.62% 23.02% 23.38% 23.62% 24.73% 24.24% 27.51% 27.36% 27.39% 27.64%
No. of Shareholders 17,70216,82117,02916,37218,13116,72128,68528,20332,01634,41544,87549,357

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls